Dan Hayes interview on HER2 status and anthracyclines

from The JNCI Podcast · host Oxford University Press

Dr. Hayes talks about how breast cancer patients’ HER2 status may change how doctors decide what type of chemotherapy they will receive.

Episode metadata supplied by the publisher feed · Published Jan 2, 2008

Embed this episode

Attribution link and audio player

NOW PLAYING

Dan Hayes interview on HER2 status and anthracyclines

0:00 13:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 13 minutes long.

This episode was published on January 2, 2008.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!